Header Logo

Connection

Naoko Takebe to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Angiogenesis Inhibitors.
Naoko Takebe
Connection Strength
0.155
Angiogenesis Inhibitors
  1. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy?in Cancer Therapy Evaluation Program-sponsored phase I trials. Eur J Cancer. 2019 07; 115:111-119.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.